147 related articles for article (PubMed ID: 32935055)
1. Identifying incident cancer cases in dispensing claims: A validation study using Australia's Repatriation Pharmaceutical Benefits Scheme (PBS) data.
Daniels B; Tervonen HE; Pearson SA
Int J Popul Data Sci; 2019 Mar; 5(1):1152. PubMed ID: 32935055
[TBL] [Abstract][Full Text] [Related]
2. Retrospective comparison of Australia's Pharmaceutical Benefits Scheme claims data with prescription data in HER2-positive early breast cancer patients, 2008-2012.
Harris C; Daniels B; Ward RL; Pearson SA
Public Health Res Pract; 2017 Dec; 27(5):. PubMed ID: 31044212
[TBL] [Abstract][Full Text] [Related]
3. Patterns of opioid use in older people diagnosed with cancer in New South Wales, Australia.
Tervonen HE; Schaffer AL; Luckett T; Phillips J; Litchfield M; Todd A; Pearson SA
Pharmacoepidemiol Drug Saf; 2021 Mar; 30(3):360-370. PubMed ID: 33047458
[TBL] [Abstract][Full Text] [Related]
4. Studies using Australia's Pharmaceutical Benefits Scheme data for pharmacoepidemiological research: a systematic review of the published literature (1987-2013).
Pearson SA; Pesa N; Langton JM; Drew A; Faedo M; Robertson J
Pharmacoepidemiol Drug Saf; 2015 May; 24(5):447-55. PubMed ID: 25833702
[TBL] [Abstract][Full Text] [Related]
5. Patterns of oxycodone controlled release use in older people with cancer following public subsidy of oxycodone/naloxone formulations: An Australian population-based study.
Daniels B; Luckett T; Holliday S; Liauw W; Lovell M; Phillips J; Rowett D; John TN; Tervonen H; Pearson SA
Asia Pac J Clin Oncol; 2021 Feb; 17(1):68-78. PubMed ID: 32924282
[TBL] [Abstract][Full Text] [Related]
6. Prescription opioid dispensing in New South Wales, Australia: spatial and temporal variation.
Islam MM; McRae IS; Mazumdar S; Simpson P; Wollersheim D; Fatema K; Butler T
BMC Pharmacol Toxicol; 2018 Jun; 19(1):30. PubMed ID: 29914572
[TBL] [Abstract][Full Text] [Related]
7. To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?
Gisev N; Pearson SA; Karanges EA; Larance B; Buckley NA; Larney S; Dobbins T; Blanch B; Degenhardt L
Pharmacoepidemiol Drug Saf; 2018 May; 27(5):550-555. PubMed ID: 29047196
[TBL] [Abstract][Full Text] [Related]
8. Use of analgesics following rescheduling of codeine in Australia: An interrupted time series analysis in the veteran population.
Kalisch Ellett LM; Kemp-Casey A; Kassie GM; Pratt NL; Roughead EE
Int J Drug Policy; 2020 Jul; 81():102767. PubMed ID: 32416524
[TBL] [Abstract][Full Text] [Related]
9. Validating a proxy for disease progression in metastatic cancer patients using prescribing and dispensing data.
Joshi V; Adelstein BA; Schaffer A; Srasuebkul P; Dobbins T; Pearson SA;
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e246-e252. PubMed ID: 27665738
[TBL] [Abstract][Full Text] [Related]
10. Prescription opioid dispensing in Australian children and adolescents: a national population-based study.
Bell J; Paget SP; Nielsen TC; Buckley NA; Collins J; Pearson SA; Nassar N
Lancet Child Adolesc Health; 2019 Dec; 3(12):881-888. PubMed ID: 31604614
[TBL] [Abstract][Full Text] [Related]
11. Validation and application of a death proxy in adult cancer patients.
Mealing NM; Dobbins TA; Pearson SA
Pharmacoepidemiol Drug Saf; 2012 Jul; 21(7):742-748. PubMed ID: 22020956
[TBL] [Abstract][Full Text] [Related]
12. Validation of a proxy for estrogen receptor status in breast cancer patients using dispensing data.
Srasuebkul P; Dobbins TA; ; Pearson SA
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e63-8. PubMed ID: 23176304
[TBL] [Abstract][Full Text] [Related]
13. Prescription opioid analgesics for pain management in Australia: 20 years of dispensing.
Islam MM; McRae IS; Mazumdar S; Taplin S; McKetin R
Intern Med J; 2016 Aug; 46(8):955-63. PubMed ID: 26602489
[TBL] [Abstract][Full Text] [Related]
14. The use and impact of cancer medicines in routine clinical care: methods and observations in a cohort of elderly Australians.
Pearson SA; Schaffer A
BMJ Open; 2014 May; 4(5):e004099. PubMed ID: 24793244
[TBL] [Abstract][Full Text] [Related]
15. A comparison of opioids and benzodiazepines dispensing in Australia.
Islam MM; Wollersheim D
PLoS One; 2019; 14(8):e0221438. PubMed ID: 31425552
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic and other medicine use at time of death by suicide: a population-level analysis of linked dispensing and forensic toxicology data.
Chitty KM; Buckley NA; Lim J; Ali Z; Schumann JL; Cairns R; Daniels B; Pearson SA; Preen DB; Schaffer AL
Med J Aust; 2023 Jul; 219(2):63-69. PubMed ID: 37230472
[TBL] [Abstract][Full Text] [Related]
17. Brand substitution or multiple switches per patient? An analysis of pharmaceutical brand substitution in Australia.
Kalisch LM; Roughead EE; Gilbert AL
Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):620-5. PubMed ID: 18324613
[TBL] [Abstract][Full Text] [Related]
18. Identifying incident colorectal and lung cancer cases in health service utilisation databases in Australia: a validation study.
Goldsbury D; Weber M; Yap S; Banks E; O'Connell DL; Canfell K
BMC Med Inform Decis Mak; 2017 Feb; 17(1):23. PubMed ID: 28241763
[TBL] [Abstract][Full Text] [Related]
19. Dispensing patterns of medicines prescribed by Australian dentists from 2006 to 2018 - a pharmacoepidemiological study.
Park JS; Page AT; Kruger E; Tennant M
Int Dent J; 2020 Aug; 71(2):106-12. PubMed ID: 32856305
[TBL] [Abstract][Full Text] [Related]
20. Minimal excess risk of cancer and reduced risk of death from cancer in Australian Department of Veterans' Affairs clients: a record linkage study.
Vajdic CM; Stavrou EP; Ward RL; Falster MO; Pearson SA
Aust N Z J Public Health; 2014 Feb; 38(1):30-4. PubMed ID: 24494942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
